Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Lenalidomide

EU orphan designation number: EU/3/07/494   
Active ingredient: Lenalidomide
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Celgene Europe Limited
1 Longwalk Road, Stockley Park, Uxbridge, Middlesex UB11 1DB, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
21/11/2007 Centralised Orphan - Designation EMEA/OD/068/07 (2007)5660 of 19/11/2007
26/10/2008 Other procedure
30/05/2011 Centralised Orphan - Change of address EMEA/OD/068/07